![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
20
Micro Labs Limited Bengaluru In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Torasemide, Process II, supported by a 'Suspended by EDQM GMP non-compliance' Certificate of Suitability (CEP) with the number R0-CEP 2023-057 - Rev 00
This Chemical Type CEP, issued on April 28, 2023, remains in force until April 29, 2024, ensuring its reliability within the pharmaceutical industry.
Substance Number 2132 associated with this CEP further emphasizes